Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects.
Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects.
复制标题
DOI:
10.1016/j.jaci.2022.02.026
复制
发表时间:
2022-10
影响因子:
14.2
通讯作者:
Figueiredo, Camila A.
中科院分区:
文献类型:
--
作者:
Johnson, Randi K.;Manke, Jonathan;Campbell, Monica;Armstrong, Michael;Boorgula, Meher Preethi;Pinheiro, Gabriela;Santana, Cinthia Vila Nova;Mathias, Rasika A.;Barnes, Kathleen C.;Cruz, Alvaro;Reisdorph, Nichole;Figueiredo, Camila A.
Lipid mediators, bioactive products of polyunsaturated fatty acid metabolism, contribute to inflammation initiation and resolution in allergic diseases; however, their presence in lung-related biosamples has not been fully described. We aimed to quantify lipid mediators in the nasal airway epithelium and characterize preliminary associations with asthma. Using liquid chromatography mass-spectrometry, we conducted a pilot study to quantify 56 lipid mediators from nasal epithelial samples collected from 11 female participants of an outpatient asthma clinic and community controls (aged 30–55 years). We examined the presence of each compound using descriptive statistics to test whether lipid mediators could distinguish asthma (n=8) from control subjects (n=3) using linear regression and partial least squares-discriminant analysis (PLS-DA). For detailed Methods, please see this article’s Online Repository at www.jacionline.org. Fifteen lipid mediators were detectable in all samples, including Resolvin D5 (RVD5), with the highest median concentrations (in pg per μg protein) of 13-HODE (126.481), 15-HETE (32.869), and 13-OxoODE (13.251). From linear regression adjusted for age, prostaglandin E2 (PGE2) had a trend (p<0.1) for higher concentrations in severe asthma cases compared to controls (mean difference = 0.95, 95%CI: −0.04–1.95). Asthma cases had higher scores on principal component 3 compared to controls (mean difference = 2.42, 95%CI: 0.89–3.96), which represented lower levels of pro-resolving 15-HEPE, 19, 20-DiHDPA, RVD5, 14-HDHA, 17-HDHA, and 13-HOTrE. Most of these compounds were most influential in discriminating asthma cases from controls in PLS-DA. Lipid mediators are detectable in the nasal epithelium and their levels distinguish asthma cases from controls. NA We described lipid mediator concentrations in the nasal epithelium and identified combinations of pro-resolving molecules that discriminate asthma cases from controls. Measurement of these compounds in this tissue is feasible for larger asthma studies.
登录
查看更多内容
影响因子:
4.1
作者:
Polinski KJ;Armstrong M;Manke J;Seifert J;Crume T;Yang F;Clare-Salzler M;Holers VM;Reisdorph N;Norris JM
通讯作者:
Norris JM
DOI:
10.1016/j.bbalip.2010.08.002
发表时间:
2010-12
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
Bannenberg G;Serhan CN
通讯作者:
Serhan CN
影响因子:
6.1
作者:
Aggarwal, S.;Moodley, Y. P.;Misso, N. L.
通讯作者:
Misso, N. L.
影响因子:
2.4
作者:
Barker, M;Rayens, W
通讯作者:
Rayens, W
影响因子:
14.2
作者:
Imkamp, Kai;Berg, Marijn;Faiz, Alen
通讯作者:
Faiz, Alen